Dr. Josef Penninger
-
The report provides insights into food price trends, affordability challenges and the broader forces shaping Canada’s food systems.
-
Potential ‘Achilles’ heel’ of SARS-CoV-2 virus captured on video
Proteins known as lectins can bind to the spike protein on the SARS-CoV-2 virus and prevent it from accessing human cells, an international team of researchers led by the University of British Columbia’s Dr. Josef Penninger has demonstrated.
-
UBC scientist identifies a gene that controls thinness
Why can some people eat as much as they want, and still stay thin?
-
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
-
Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19
A University of British Columbia researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in China.
